Trials / Conditions / HPV-Related Cervical Carcinoma

HPV-Related Cervical Carcinoma

28 registered clinical trials studyying HPV-Related Cervical Carcinoma — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes NCT06640283	Instituto do Cancer do Estado de São Paulo	Phase 2
Recruiting	A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer NCT06319963	Theravectys S.A.	Phase 1 / Phase 2
Active Not Recruiting	A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) NCT05973487	TScan Therapeutics, Inc.	Phase 1
Withdrawn	Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Ca NCT06099418	Nykode Therapeutics ASA	Phase 2
Recruiting	Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples NCT06598176	Universiteit Antwerpen	N/A
Recruiting	Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women NCT05829629	BlueSky Immunotherapies GmbH	Phase 1
Recruiting	Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With NCT06052033	First Affiliated Hospital of Wenzhou Medical University	N/A
Completed	Self-collected Vaginal and Urine Samples in HIV-positive Women NCT05783167	University of Aarhus	—
Active Not Recruiting	Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSel NCT05996783	Universiteit Antwerpen	N/A
Completed	Dry Run of the ScreenUrSelf Trial NCT05996796	Universiteit Antwerpen	N/A
Active Not Recruiting	HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis NCT06339684	Fondazione IRCCS Policlinico San Matteo di Pavia	—
Recruiting	E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers NCT05686226	Christian Hinrichs	Phase 2
Terminated	This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Sele NCT05061940	Repertoire Immune Medicines	—
Completed	Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial NCT04679675	Kaiser Permanente	N/A
Recruiting	Detecting HPV DNA in Anal and Cervical Cancers NCT04857528	University of Chicago	—
Completed	CASUS: Validation for Detection of Precursor Lesions NCT04530201	Universiteit Antwerpen	N/A
Completed	Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha NCT04436133	National Vaccine and Serum Institute, China	Phase 2
Completed	A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunog NCT04083196	National Vaccine and Serum Institute, China	Phase 1
Completed	CASUS: Improved and Quality Assured Collection of First-void Urine NCT04480866	Universiteit Antwerpen	N/A
Completed	Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV Vaccination NCT03888599	University Hospital, Geneva	—
Unknown	Acceptability of Self-sampling for Cervical Cancer Screening NCT05314907	Institut d'Investigació Biomèdica de Bellvitge	N/A
Completed	HPV in Sentinel Lymph Nodes of Cervical Cancer Patients NCT03749707	University of Aarhus	N/A
Active Not Recruiting	Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers NCT03260023	Transgene	Phase 1 / Phase 2
Completed	Effectiveness of Targeted Educational Interventions at Increasing HPV Vaccine Acceptability and Uptake NCT03337269	University of Pennsylvania	N/A
Completed	An Observational Study of GP Verbal Reminders Upon Cervical Screening NCT04970394	Dr. Faizan Awan	—
Completed	FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program NCT03105856	Instituto Nacional de Salud Publica, Mexico	Phase 4
Unknown	HPV Infection and Cervical Neoplasm in Women With Inflammatory Bowel Disease: a Cross-sectional Study NCT03055130	Sixth Affiliated Hospital, Sun Yat-sen University	—
Completed	STI Knowledge and HPV Vaccine Acceptance in Bamako, Mali in 2012 NCT05767138	Global Alliance to Immunize Against AIDS Vaccine Foundation	—